IS4570A - Imidazo [1,2-a] pyridine derivatives - Google Patents

Imidazo [1,2-a] pyridine derivatives

Info

Publication number
IS4570A
IS4570A IS4570A IS4570A IS4570A IS 4570 A IS4570 A IS 4570A IS 4570 A IS4570 A IS 4570A IS 4570 A IS4570 A IS 4570A IS 4570 A IS4570 A IS 4570A
Authority
IS
Iceland
Prior art keywords
imidazo
pyridine derivatives
pyridine
derivatives
Prior art date
Application number
IS4570A
Other languages
Icelandic (is)
Inventor
John Beswick Paul
Baxter Campbell Ian
Naylor Alan
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9506965.4A external-priority patent/GB9506965D0/en
Priority claimed from GBGB9512099.4A external-priority patent/GB9512099D0/en
Priority claimed from GBGB9516117.0A external-priority patent/GB9516117D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS4570A publication Critical patent/IS4570A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
IS4570A 1995-04-04 1997-09-25 Imidazo [1,2-a] pyridine derivatives IS4570A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9506965.4A GB9506965D0 (en) 1995-04-04 1995-04-04 Chemical compounds
GBGB9512099.4A GB9512099D0 (en) 1995-06-14 1995-06-14 Chemical compounds
GBGB9516117.0A GB9516117D0 (en) 1995-08-05 1995-08-05 Chemical compounds
PCT/EP1996/001438 WO1996031509A1 (en) 1995-04-04 1996-04-02 IMIDAZO[1,2-a]PYRIDINE DERIVATIVES

Publications (1)

Publication Number Publication Date
IS4570A true IS4570A (en) 1997-09-25

Family

ID=27267657

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4570A IS4570A (en) 1995-04-04 1997-09-25 Imidazo [1,2-a] pyridine derivatives

Country Status (17)

Country Link
EP (1) EP0819127A1 (en)
JP (1) JPH11501049A (en)
KR (1) KR19980703559A (en)
CN (1) CN1186492A (en)
AU (1) AU5276696A (en)
BG (1) BG101934A (en)
CA (1) CA2216809A1 (en)
CZ (1) CZ313397A3 (en)
EA (1) EA199700209A1 (en)
HU (1) HUP9801602A3 (en)
IS (1) IS4570A (en)
NO (1) NO974595L (en)
NZ (1) NZ304886A (en)
PL (1) PL322623A1 (en)
SK (1) SK133297A3 (en)
TR (1) TR199701105T1 (en)
WO (1) WO1996031509A1 (en)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764292B1 (en) * 1997-06-10 2000-12-29 Innothera Lab Sa USE OF DICETONIC TETRACYCLE DERIVATIVES, NOVEL COMPOUNDS OBTAINED AND THEIR APPLICATION IN THERAPEUTICS
US6525053B1 (en) 1997-08-22 2003-02-25 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
US6307047B1 (en) 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
WO1999012930A1 (en) 1997-09-05 1999-03-18 Glaxo Group Limited 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their prepa ration and their use as cyclooxygenase 2 (cox-2) inhibitors
FR2770131A1 (en) * 1997-10-27 1999-04-30 Union Pharma Scient Appl Analgesic combinations of a cyclooxygenase-2 inhibitor and acetaminophen or an opiate having synergistic activity
FR2771005B1 (en) * 1997-11-18 2002-06-07 Union Pharma Scient Appl NEW PHARMACEUTICAL ASSOCIATION WITH ANALGESIC ACTIVITY
GB9810920D0 (en) * 1998-05-21 1998-07-22 Merck Sharp & Dohme Therapeutic use
ES2140354B1 (en) * 1998-08-03 2000-11-01 S A L V A T Lab Sa IMIDAZO (1,2A) AZINAS SUBSTITUTED AS SELECTIVE INHIBITORS OF COX-2.
TW587079B (en) * 1998-09-25 2004-05-11 Almirall Prodesfarma Ag 2-phenylpyran-4-one derivatives
WO2000026216A1 (en) 1998-11-03 2000-05-11 Glaxo Group Limited Pyrazolopyridine derivatives as selective cox-2 inhibitors
JP2002538157A (en) 1999-02-27 2002-11-12 グラクソ グループ リミテッド Pyrazolopyridine
GB9930358D0 (en) 1999-12-22 2000-02-09 Glaxo Group Ltd Process for the preparation of chemical compounds
RU2002119574A (en) 1999-12-23 2004-01-10 Нитромед, Инк. (Us) Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions based on them and methods for their use
GB0002312D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
PE20011333A1 (en) 2000-03-16 2002-01-16 Almirall Prodesfarma Ag DERIVATIVES OF 2-FENYLPYRAN-4-ONA AS INHIBITORS OF CYCLOOXYGENASE 2
PE20020146A1 (en) * 2000-07-13 2002-03-31 Upjohn Co OPHTHALMIC FORMULATION INCLUDING A CYCLOOXYGENASE-2 (COX-2) INHIBITOR
ATE366569T1 (en) 2000-07-20 2007-08-15 Lauras As USE OF COX-2 INHIBITORS AS IMMUNOSTIMULANTS FOR THE TREATMENT OF HIV OR AIDS
PE20020506A1 (en) 2000-08-22 2002-07-09 Glaxo Group Ltd PIRAZOLE DERIVATIVES FUSED AS PROTEIN KINASE INHIBITORS
GB0025449D0 (en) * 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
EP1341788B1 (en) 2000-12-15 2005-08-10 Glaxo Group Limited Pyrazolopyridines
ATE300541T1 (en) 2000-12-15 2005-08-15 Glaxo Group Ltd PYRAZOLOPYRIDINE DERIVATIVES
WO2002072581A2 (en) 2001-03-08 2002-09-19 Smithkline Beecham Corporation Pyrazolopyriadine derivatives
JP4237497B2 (en) 2001-03-30 2009-03-11 スミスクライン ビーチャム コーポレーション Pyrazolopyridines, their preparation and their use as therapeutic compounds
US7695736B2 (en) 2001-04-03 2010-04-13 Pfizer Inc. Reconstitutable parenteral composition
DE60212949T2 (en) 2001-04-10 2007-01-04 Smithkline Beecham Corp. ANTIVIRAL PYRAZOLOPYRIDINE COMPOUNDS
US6756498B2 (en) 2001-04-27 2004-06-29 Smithkline Beecham Corporation Process for the preparation of chemical compounds
WO2002088124A2 (en) 2001-04-27 2002-11-07 Smithkline Beecham Corporation Pyrazolo'1,5-a!pyridine derivatives
EP1401836B1 (en) 2001-06-21 2006-08-23 SmithKline Beecham Corporation Imidazo¬1,2-a|pyridine derivatives for the prophylaxis and treatment of herpes viral infections
AR038957A1 (en) 2001-08-15 2005-02-02 Pharmacia Corp COMBINATION THERAPY FOR CANCER TREATMENT
ES2262893T3 (en) 2001-10-05 2006-12-01 Smithkline Beecham Corporation IMIDAZO-PIRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF VIRIC INFECTION BY HERPES.
GB0124938D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124934D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124931D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124933D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124936D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124941D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124939D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
US7199120B2 (en) 2001-12-11 2007-04-03 Smithkline Beecham Corporation Pyrazolo-pyridine derivatives as antiherpes agents
DE60334651D1 (en) 2002-02-12 2010-12-02 Glaxosmithkline Llc Nicotinamide and its use as P38 inhibitors
CA2492066A1 (en) 2002-06-28 2004-01-08 Nitromed, Inc. Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
GB0217757D0 (en) 2002-07-31 2002-09-11 Glaxo Group Ltd Novel compounds
US7153863B2 (en) 2002-10-03 2006-12-26 Smithkline Beecham Corporation Therapeutic compounds based on pyrazolopyridline derivatives
KR20040072004A (en) 2003-02-07 2004-08-16 삼성에스디아이 주식회사 Emitting compound for electroluminescence device and device using thereof
GB0308186D0 (en) 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
GB0308185D0 (en) 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
GB0308201D0 (en) 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
DE602004002832T2 (en) 2003-05-07 2007-06-06 Osteologix A/S TREATMENT OF CARTILAGE / BONE DISEASES WITH WATER-SOLUBLE STRONTIUM SALTS
GB0318814D0 (en) 2003-08-11 2003-09-10 Smithkline Beecham Corp Novel compounds
US8067464B2 (en) 2004-10-04 2011-11-29 Nitromed, Inc. Compositions and methods using apocynin compounds and nitric oxide donors
US20090018091A1 (en) 2005-08-02 2009-01-15 Nitromed, Inc. Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of Use
AU2007243765A1 (en) 2006-03-29 2007-11-08 Nicox S.A. Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
EP2086979B1 (en) 2006-11-06 2015-06-03 Tolero Pharmaceuticals, Inc. Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
HUE052198T2 (en) 2011-07-21 2021-04-28 Sumitomo Dainippon Pharma Oncology Inc Heterocyclic protein kinase inhibitors
WO2016177776A1 (en) 2015-05-04 2016-11-10 Academisch Medisch Centrum Biomarkers for the detection of aspirin insensitivity
JP2022520361A (en) 2019-02-12 2022-03-30 スミトモ ダイニッポン ファーマ オンコロジー， インコーポレイテッド Pharmaceuticals containing heterocyclic protein kinase inhibitors
IL305573A (en) 2021-03-15 2023-10-01 Saul Yedgar HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455924A (en) * 1967-02-08 1969-07-15 Upjohn Co Dianisylimidazoles

Also Published As

Publication number Publication date
PL322623A1 (en) 1998-02-02
SK133297A3 (en) 1998-07-08
NZ304886A (en) 1998-11-25
NO974595L (en) 1997-12-03
AU5276696A (en) 1996-10-23
HUP9801602A3 (en) 1999-01-28
CA2216809A1 (en) 1996-10-10
EP0819127A1 (en) 1998-01-21
WO1996031509A1 (en) 1996-10-10
KR19980703559A (en) 1998-11-05
MX9707379A (en) 1997-11-29
EA199700209A1 (en) 1998-04-30
CN1186492A (en) 1998-07-01
NO974595D0 (en) 1997-10-03
CZ313397A3 (en) 1998-03-18
BG101934A (en) 1999-04-30
JPH11501049A (en) 1999-01-26
HUP9801602A2 (en) 1998-11-30
TR199701105T1 (en) 1998-02-21

Similar Documents

Publication Publication Date Title
IS4570A (en) Imidazo [1,2-a] pyridine derivatives
EE200200080A (en) Imidazo [1,2a] pyridine and pyrazolo [2,3a] pyridine derivatives
DE69804273D1 (en) 5h-thiazolo [3,2-a] pyrimidine derivatives
DE69529777T2 (en) 2-benzylthio-8-amino (1,2,4) triazolo (1,5-a) pyridine
MX9202838A (en) IMIDAZO [1,5-A] QUINOXALINAS.
DE69800896T2 (en) 8-substituted-1,3,8-triazaspiro [4,5] decan-4-one derivatives
IL117824A0 (en) Use of imidazo [1,2-alpha] pyridine-3-acetamide derivatives
DE69803653T2 (en) 1,3,8-triazaspiro [4,5] decan-4-one derivatives
DE59009117D1 (en) [1,2,4] triazolo [1,5-a] pyridines.
PT837860E (en) 5,6-DIHYDRO-9H-PYRAZOLO-3,4-C | -1,2,4-TRIAZOLO-4,3-ALPHA | TRYCYLIC PYRIDINES
DE69502542T2 (en) 2-phenyl-7-chloro-perhydroimidazo (1,5-a) pyridine
AU2253297A (en) Imidazo{1,2-a}pyridine c-nucleosides as antiviral agents
AU698867B2 (en) Fused imidazo 1,2-a pyridines
NO982843D0 (en) 2,7-Substituted octahydro-pyrrole £ 1,2-apyrazine derivatives
DE69824872D1 (en) 1,2,3,4-TETRAHYDRO-BENZOFURO [3,2-C] PYRIDINE DERIVATIVES
HUP0003692A3 (en) Pyrimido[4,5-b]indolyl-alkanecarboxamide derivatives
BR9609892A (en) Imidazopyridine derivatives
ZA957309B (en) New thiazolo[3,2-a]quinoline and -naphthyridine derivatives
ZA966559B (en) Imidazopyridine derivatives.
IL121360A0 (en) Imidazopyridine derivatives
BR9603253A (en) Camptothecin derivatives